Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Daily News

Eclampsia in Pregnancy Sharply Increases Risk of CVD in the Year After Delivery

Caitlin E. Cox

July 31, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

Heart Disease Treatment Costs $100 Billion per Year in the US

L.A. McKeown

July 30, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Daily News

Physical Activity Ebbs, Flows Over a Lifetime but Rarely Rebounds After CVD

Caitlin E. Cox

July 23, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients

Caitlin E. Cox

July 14, 2025

News Daily News

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

Todd Neale

July 09, 2025

News Daily News

Prepregnancy CV Health Portends Midlife Risks: CARDIA Analysis

L.A. McKeown

June 27, 2025

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

L.A. McKeown

June 17, 2025

News Daily News

Societies Push CV Trialists to Recruit More Women

L.A. McKeown

June 04, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms

Caitlin E. Cox

April 28, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

L.A. McKeown

April 15, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

Advertisement

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Eclampsia in Pregnancy Sharply Increases Risk of CVD in the Year After Delivery

TCTMD’s Top 10 Most Popular Stories for July 2025

Heart Disease Treatment Costs $100 Billion per Year in the US

July 2025 Dispatch for the CV Team

Physical Activity Ebbs, Flows Over a Lifetime but Rarely Rebounds After CVD

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

Prepregnancy CV Health Portends Midlife Risks: CARDIA Analysis

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

Societies Push CV Trialists to Recruit More Women

May 2025 Dispatch for the CV Team

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms

Cardiotoxicity Rare With Common GI Chemotherapy

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content